Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
2
×
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
archive
astrazeneca
biogen
biotech
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
coronavirus
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
forty seven
fred hutch
general atlantic
gilead sciences
givosiran
imara
immunocore
indiana blog main
indiana top stories
What
covid
2
×
help
2
×
acquisitions
announced
bio
biotherapeutics
ceo
collabs
companies
daniel
deal
effective
formulated
gilead
gilead’s
hospitalized
initially
introduce
ipo
isn’t
medicines
merck
merck’s
molnupiravir
month
one’s
o’day
pharmaceutical
pill
plans
published
quite
reducing
reported
ridgeback
risk
roundup
sciences
transformative
treat
Language
unset
Current search:
covid
×
help
×
fda
×
@slashgear.com
2 years ago
Merck’s COVID-19 pill isn’t quite as effective as initially reported
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
